132 related articles for article (PubMed ID: 8504717)
1. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?].
Wehmeier A; Schneider W
Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717
[No Abstract] [Full Text] [Related]
2. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
Zankovich R; Thiele J; Mödder B; Steinberg T; Simon KG; Fischer R; Diehl V
Med Klin (Munich); 1988 Oct; 83(19):617-28. PubMed ID: 3185420
[No Abstract] [Full Text] [Related]
3. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
Wilkins BS
Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
[No Abstract] [Full Text] [Related]
4. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly].
Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T
Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435
[No Abstract] [Full Text] [Related]
5. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
[No Abstract] [Full Text] [Related]
6. A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis.
Chen F; Zhang C; Wang W; Li L; Yan S; Sun J; Zhang M; Ji C; Hou M
Leuk Res; 2008 Apr; 32(4):665-7. PubMed ID: 17854891
[TBL] [Abstract][Full Text] [Related]
7. [Chronic myeloproliferative diseases].
Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
[No Abstract] [Full Text] [Related]
8. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
Nagao T; Yonekura S
Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
[No Abstract] [Full Text] [Related]
10. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
[TBL] [Abstract][Full Text] [Related]
11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
12. [Chronic myeloproliferative diseases. 3: Osteomyelofibrosis].
Zankovich R
Fortschr Med; 1989 Nov; 107(34):736-40. PubMed ID: 2606418
[No Abstract] [Full Text] [Related]
13. [Bioptic medullary findings for the formation of fibres in attended and not yet attended myeloses (author's transl)].
Hill K; Dennhardt HH
Verh Dtsch Ges Pathol; 1972; 56():587-92. PubMed ID: 4130904
[No Abstract] [Full Text] [Related]
14. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
Thiele J; Kvasnicka HM; Vardiman J
Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
Yonekura S
Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
[No Abstract] [Full Text] [Related]
16. [Vascular changes in bone marrow in blood diseases].
Demmler K; Burkhardt R
Med Klin; 1980 Apr; 75(9):328-32. PubMed ID: 7402170
[No Abstract] [Full Text] [Related]
17. [Problems of the myeloproliferative syndrome from the pathologist's viewpoint].
Werner W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):227-34. PubMed ID: 4184585
[No Abstract] [Full Text] [Related]
18. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
Kvasnicka HM; Thiele J
Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
[TBL] [Abstract][Full Text] [Related]
19. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic parameters of altered collagen turnover.
Hahn EG; Hochweiss S; Berk PD
Prog Clin Biol Res; 1984; 154():335-43. PubMed ID: 6382302
[No Abstract] [Full Text] [Related]
[Next] [New Search]